Introduction to Common Brand-Name Drugs in Urology

A pharmacist works on a prescription.
A pharmacist works on a prescription. Musketeer/Getty Images

There are numerous brand-name drugs in urology -- the surgical specialty that deals with diseases of the male and female urinary tract and the male reproductive organs. Brand-name drugs are sold by the pharmaceutical company who developed them. These drugs are trademark-protected by the company. That means that only the company who holds the patent can manufacture and market them in the original formulation.

Brand-Name Drugs vs. Generic Drugs

After a certain period of time, brand-name drugs go "off patent," making it possible for other drug companies to produce what is known as a generic drug -- a therapeutic equivalent to the original brand-name drug. Brand-name drugs are generally more expensive than generic drugs. Because of this difference in price, health plan drug formularies, the lists of drugs that your health plan will cover, typically encourage the use of generic drugs based on price and therapeutic equivalence.

Common Brand-Name Drugs in Urology

Examples of common brand-name drugs in urology are Flomax and Avodart, which are used to treat an enlarged prostate, something that happens to almost all men as they get older. The drugs are also now available as generic drugs: tamsulosin hydrochloride (Flomax) and dutasteride (Avodart).

In 2015, the Food and Drug Administration approved Avycaz for the treatment of complicated intra-abdominal and urinary tract infections.

Also in 2015, the FDA approved Xuriden for the treatment of hereditary orotic aciduria.

Another brand-name drug used to treat intra-abdominal and urinary tract infections is Zerbaxa, which was approved in 2014. Xiafex is used to treat Peyronie's disease (the development of fibrous scar tissue inside the penis that causes curved, painful erections).

Another example of a brand-drug in urology is Detrol, generic name tolterodine tartrate, which is prescribed for overactive bladder (an increased urge to urinate, frequent urination, and inability to control urination).

Zytiga was approved by the FDA in 2011 for the treatment of prostate cancer. Xofigo (approved in 2013) treats prostate cancer with bone metastases (prostate cancer that has spread to bones). Jevtana is another drug (approved in 2010) used to treat prostate cancer.

Bio-T-Gel, or testosterone gel, was developed for the treatment of hypogonadism. Male hypogonadism is a condition in which the body doesn't produce enough testosterone — the hormone that plays a key role in masculine growth and development during puberty — or has an impaired ability to produce sperm or both.

Another brand-name drug in urology is Provenge which was developed specifically for the treatment of hormone-refractory prostate cancer.

Working with Your Urologist

There are numerous other brand-name drugs in urology that treat everything from advanced stage prostate cancer to ovulation induction for the treatment of infertility. In order to know what medications (if any) may suit your unique health concerns, find a urologist in your area.


Center Watch. FDA Approved Drugs for Urology.

Mayo Clinic.

The PDR Pocket Guide to Prescription Drugs. 8th ed. New York: Pocket Books, 2008.

Continue Reading